When it comes to breast carcinoma models, our previous study was the first report to show the time dependent increase in endogenous IL-33 in primary 4T1 mammary tumors in BALB/c mice during cancer progression, as assessed by increased IL-33 mRNA and protein levels accompanied with the time-dependent increase in ST2 mRNA levels [54]. The gene discussed is IL33; the disease is breast carcinoma.